NCT01470326View on ClinicalTrials.gov

Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan)

CompletedOBSERVATIONAL
Enrollment

3,187

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Osteoporosis
Interventions
DRUG

Bazedoxifene

For adults, take 1 tablet (20 mg of the active ingredient) at a time, once a day.

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01470326 - Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan) | Biotech Hunter | Biotech Hunter